The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In Vitro Diagnostics (IVD) Products and Test-Global Market Insights and Sales Trends 2025
Synopsis
The global In Vitro Diagnostics (IVD) Products and Test market size is expected to reach US$ 126530 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics (IVD) Products and Test in various end use industries. The expanding demands from the Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing and Immunochemistry, are propelling In Vitro Diagnostics (IVD) Products and Test market. General Chemistries, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Critical Care segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Products and Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics (IVD) Products and Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics (IVD) Products and Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics (IVD) Products and Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics (IVD) Products and Test covered in this report include Abbott Laboratories(US), Becton Dickinson Company(US), bioMerieux SA(France), F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare(Germany), Alere Inc(US), Beckman Coulter, Inc.(US), Bio-Rad Laboratories(US) and Hologic(US), etc.
The global In Vitro Diagnostics (IVD) Products and Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories(US)
Becton Dickinson Company(US)
bioMerieux SA(France)
F. Hoffmann-La Roche Ltd.(Switzerland)
Siemens Healthcare(Germany)
Alere Inc(US)
Beckman Coulter, Inc.(US)
Bio-Rad Laboratories(US)
Hologic(US)
Ortho Clinical Diagnostics(US)
Roche Diagnostics(US)
Global In Vitro Diagnostics (IVD) Products and Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics (IVD) Products and Test market, Segment by Type:
General Chemistries
Critical Care
Urinalysis
Analyzers Blood Gases
Workstations
Others
Global In Vitro Diagnostics (IVD) Products and Test market, by Application
Molecular Diagnostics
Clinical Chemistry
Diabetes and Glucose Testing
Immunochemistry
Hematology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics (IVD) Products and Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global In Vitro Diagnostics (IVD) Products and Test market size is expected to reach US$ 126530 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics (IVD) Products and Test in various end use industries. The expanding demands from the Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing and Immunochemistry, are propelling In Vitro Diagnostics (IVD) Products and Test market. General Chemistries, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Critical Care segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Products and Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics (IVD) Products and Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics (IVD) Products and Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics (IVD) Products and Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics (IVD) Products and Test covered in this report include Abbott Laboratories(US), Becton Dickinson Company(US), bioMerieux SA(France), F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare(Germany), Alere Inc(US), Beckman Coulter, Inc.(US), Bio-Rad Laboratories(US) and Hologic(US), etc.
The global In Vitro Diagnostics (IVD) Products and Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories(US)
Becton Dickinson Company(US)
bioMerieux SA(France)
F. Hoffmann-La Roche Ltd.(Switzerland)
Siemens Healthcare(Germany)
Alere Inc(US)
Beckman Coulter, Inc.(US)
Bio-Rad Laboratories(US)
Hologic(US)
Ortho Clinical Diagnostics(US)
Roche Diagnostics(US)
Global In Vitro Diagnostics (IVD) Products and Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics (IVD) Products and Test market, Segment by Type:
General Chemistries
Critical Care
Urinalysis
Analyzers Blood Gases
Workstations
Others
Global In Vitro Diagnostics (IVD) Products and Test market, by Application
Molecular Diagnostics
Clinical Chemistry
Diabetes and Glucose Testing
Immunochemistry
Hematology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics (IVD) Products and Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In Vitro Diagnostics (IVD) Products and Test
1.1 In Vitro Diagnostics (IVD) Products and Test Market Overview
1.1.1 In Vitro Diagnostics (IVD) Products and Test Product Scope
1.1.2 In Vitro Diagnostics (IVD) Products and Test Market Status and Outlook
1.2 Global In Vitro Diagnostics (IVD) Products and Test Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vitro Diagnostics (IVD) Products and Test Market Size by Region (2018-2029)
1.4 Global In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Region (2018-2023)
1.5 Global In Vitro Diagnostics (IVD) Products and Test Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
1.6.1 North America In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
1.6.2 Europe In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
1.6.3 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
1.6.4 Latin America In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
1.6.5 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size (2018-2029)
2 In Vitro Diagnostics (IVD) Products and Test Market by Type
2.1 Introduction
2.1.1 General Chemistries
2.1.2 Critical Care
2.1.3 Urinalysis
2.1.4 Analyzers Blood Gases
2.1.5 Workstations
2.1.6 Others
2.2 Global In Vitro Diagnostics (IVD) Products and Test Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Type (2018-2023)
2.2.2 Global In Vitro Diagnostics (IVD) Products and Test Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Type (2018-2029)
3 In Vitro Diagnostics (IVD) Products and Test Market Overview by Application
3.1 Introduction
3.1.1 Molecular Diagnostics
3.1.2 Clinical Chemistry
3.1.3 Diabetes and Glucose Testing
3.1.4 Immunochemistry
3.1.5 Hematology
3.1.6 Others
3.2 Global In Vitro Diagnostics (IVD) Products and Test Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Application (2018-2023)
3.2.2 Global In Vitro Diagnostics (IVD) Products and Test Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vitro Diagnostics (IVD) Products and Test Revenue Breakdown by Application (2018-2029)
4 In Vitro Diagnostics (IVD) Products and Test Competition Analysis by Players
4.1 Global In Vitro Diagnostics (IVD) Products and Test Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) Products and Test as of 2022)
4.3 Date of Key Players Enter into In Vitro Diagnostics (IVD) Products and Test Market
4.4 Global Top Players In Vitro Diagnostics (IVD) Products and Test Headquarters and Area Served
4.5 Key Players In Vitro Diagnostics (IVD) Products and Test Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Diagnostics (IVD) Products and Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories(US)
5.1.1 Abbott Laboratories(US) Profile
5.1.2 Abbott Laboratories(US) Main Business
5.1.3 Abbott Laboratories(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.1.4 Abbott Laboratories(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories(US) Recent Developments
5.2 Becton Dickinson Company(US)
5.2.1 Becton Dickinson Company(US) Profile
5.2.2 Becton Dickinson Company(US) Main Business
5.2.3 Becton Dickinson Company(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.2.4 Becton Dickinson Company(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.2.5 Becton Dickinson Company(US) Recent Developments
5.3 bioMerieux SA(France)
5.3.1 bioMerieux SA(France) Profile
5.3.2 bioMerieux SA(France) Main Business
5.3.3 bioMerieux SA(France) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.3.4 bioMerieux SA(France) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.3.5 F. Hoffmann-La Roche Ltd.(Switzerland) Recent Developments
5.4 F. Hoffmann-La Roche Ltd.(Switzerland)
5.4.1 F. Hoffmann-La Roche Ltd.(Switzerland) Profile
5.4.2 F. Hoffmann-La Roche Ltd.(Switzerland) Main Business
5.4.3 F. Hoffmann-La Roche Ltd.(Switzerland) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.4.4 F. Hoffmann-La Roche Ltd.(Switzerland) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.4.5 F. Hoffmann-La Roche Ltd.(Switzerland) Recent Developments
5.5 Siemens Healthcare(Germany)
5.5.1 Siemens Healthcare(Germany) Profile
5.5.2 Siemens Healthcare(Germany) Main Business
5.5.3 Siemens Healthcare(Germany) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.5.4 Siemens Healthcare(Germany) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthcare(Germany) Recent Developments
5.6 Alere Inc(US)
5.6.1 Alere Inc(US) Profile
5.6.2 Alere Inc(US) Main Business
5.6.3 Alere Inc(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.6.4 Alere Inc(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.6.5 Alere Inc(US) Recent Developments
5.7 Beckman Coulter, Inc.(US)
5.7.1 Beckman Coulter, Inc.(US) Profile
5.7.2 Beckman Coulter, Inc.(US) Main Business
5.7.3 Beckman Coulter, Inc.(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.7.4 Beckman Coulter, Inc.(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.7.5 Beckman Coulter, Inc.(US) Recent Developments
5.8 Bio-Rad Laboratories(US)
5.8.1 Bio-Rad Laboratories(US) Profile
5.8.2 Bio-Rad Laboratories(US) Main Business
5.8.3 Bio-Rad Laboratories(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.8.4 Bio-Rad Laboratories(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Laboratories(US) Recent Developments
5.9 Hologic(US)
5.9.1 Hologic(US) Profile
5.9.2 Hologic(US) Main Business
5.9.3 Hologic(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.9.4 Hologic(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.9.5 Hologic(US) Recent Developments
5.10 Ortho Clinical Diagnostics(US)
5.10.1 Ortho Clinical Diagnostics(US) Profile
5.10.2 Ortho Clinical Diagnostics(US) Main Business
5.10.3 Ortho Clinical Diagnostics(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.10.4 Ortho Clinical Diagnostics(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.10.5 Ortho Clinical Diagnostics(US) Recent Developments
5.11 Roche Diagnostics(US)
5.11.1 Roche Diagnostics(US) Profile
5.11.2 Roche Diagnostics(US) Main Business
5.11.3 Roche Diagnostics(US) In Vitro Diagnostics (IVD) Products and Test Products, Services and Solutions
5.11.4 Roche Diagnostics(US) In Vitro Diagnostics (IVD) Products and Test Revenue (US$ Million) & (2018-2023)
5.11.5 Roche Diagnostics(US) Recent Developments
6 North America
6.1 North America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Diagnostics (IVD) Products and Test Market Dynamics
11.1 In Vitro Diagnostics (IVD) Products and Test Industry Trends
11.2 In Vitro Diagnostics (IVD) Products and Test Market Drivers
11.3 In Vitro Diagnostics (IVD) Products and Test Market Challenges
11.4 In Vitro Diagnostics (IVD) Products and Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
